Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
No of Months
12
12
Operating Income
620.00
212.00
Less :Inter divisional transfers
0.00
0.00
Less: Excise
0.00
0.00
Net Sales
620.00
212.00
Expenditure (Ex Depriciation)
Stock Adjustments
-8.00
0.00
Raw Materials Consumed
541.00
164.00
Power & Fuel Cost
0.00
0.00
Employee Cost
13.00
7.00
Operating Expenses
7.00
2.00
General and Administration Expenses
-1.00
-1.00
Selling and Distribution Expenses
0.00
0.00
Cost of Software developments
1.00
2.00
Miscellaneous Expenses
0.00
0.00
Expenses Capitalised
0.00
0.00
Total Expenditure
574.00
183.00
Operating Profit (PBDIT) excl Other Income
45.00
28.00
Other Income
4.00
2.00
Operating Profit (PBDIT)
50.00
31.00
Interest
1.00
0.00
Profit before Depriciation and Tax
49.00
31.00
Depreciation
1.00
1.00
Profit Before Taxation & Exceptional Items
47.00
30.00
Exceptional Income / Expenses
0.00
0.00
Profit Before Tax
47.00
30.00
Provision for Tax
8.00
5.00
Profit After Tax
38.00
24.00
Extraordinary Items
0.00
0.00
Adj to Profit After Tax
0.00
0.00
Profit Balance B/F
33.00
13.00
Profit Available for appropriations
62.00
34.00
Appropriations
62.00
34.00
Equity Dividend (%)
15.00%
60.00%
Earnings Per Share
65.21
42.97
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 191.33% vs NA in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 57.77% vs NA in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 192.00% vs NA in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 58.24% vs NA in Mar 2024
Compare Profit and Loss Results of Remus Pharma.
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
620.00
405.00
215.00
53.09%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
620.00
405.00
215.00
53.09%
Expenditure (Ex Depriciation)
Stock Adjustments
-8.00
-17.00
9.00
52.94%
Raw Materials Consumed
541.00
149.00
392.00
263.09%
Power & Fuel Cost
0.00
11.00
-11.00
-100.00%
Employee Cost
13.00
96.00
-83.00
-86.46%
Operating Expenses
7.00
20.00
-13.00
-65.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
31.00
-31.00
-100.00%
Cost of Software developments
1.00
0.00
1.00
0%
Miscellaneous Expenses
0.00
26.00
-26.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
574.00
356.00
218.00
61.24%
Operating Profit (PBDIT) excl Other Income
45.00
49.00
-4.00
-8.16%
Other Income
4.00
4.00
0.00
0.00%
Operating Profit (PBDIT)
50.00
53.00
-3.00
-5.66%
Interest
1.00
10.00
-9.00
-90.00%
Profit before Depriciation and Tax
49.00
43.00
6.00
13.95%
Depreciation
1.00
9.00
-8.00
-88.89%
Profit Before Taxation & Exceptional Items
47.00
33.00
14.00
42.42%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
47.00
39.00
8.00
20.51%
Provision for Tax
8.00
9.00
-1.00
-11.11%
Profit After Tax
38.00
23.00
15.00
65.22%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
33.00
231.00
-198.00
-85.71%
Profit Available for appropriations
62.00
261.00
-199.00
-76.25%
Appropriations
62.00
261.00
-199.00
-76.25%
Equity Dividend (%)
15%
50%
-35.00
Earnings Per Share
65.21
3.24
61.97
1,912.65%
Profit And Loss - Net Sales
Net Sales 620.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 191.33% vs NA in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 45.69 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 57.77% vs NA in Mar 2024
Profit And Loss - Interest
Interest 1.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 192.00% vs NA in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 38.42 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 58.24% vs NA in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
